Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 21310 for:    United Therapeutics cell
Previous Study | Return to List | Next Study

Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
United Therapeutics
ClinicalTrials.gov Identifier:
NCT01795950
First received: February 12, 2013
Last updated: February 15, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2016
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)